Theravance Biopharma Files 8-K for Other Events
Ticker: TBPH · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1583107
| Field | Detail |
|---|---|
| Company | Theravance Biopharma, Inc. (TBPH) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, 8-k
TL;DR
Theravance Biopharma filed an 8-K for 'Other Events' on June 5th. Details are scarce, but it's a required disclosure.
AI Summary
On June 5, 2025, Theravance Biopharma, Inc. filed an 8-K report. The filing pertains to "Other Events" and does not disclose specific financial transactions or material agreements in the provided text. The company's principal executive offices are located at 901 Gateway Boulevard, South San Francisco, CA 94080.
Why It Matters
This 8-K filing indicates Theravance Biopharma is reporting an event not covered by other standard 8-K items, requiring public disclosure. Investors should look for further details to understand the nature and impact of this event.
Risk Assessment
Risk Level: low — The filing is a standard disclosure for 'Other Events' and does not contain information that inherently increases risk.
Key Players & Entities
- Theravance Biopharma, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event Reported
- 901 Gateway Boulevard (location) — Principal executive offices address
- South San Francisco, CA 94080 (location) — Principal executive offices address
FAQ
What specific event is Theravance Biopharma reporting under 'Other Events'?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 5, 2025.
Where are Theravance Biopharma's principal executive offices located?
Theravance Biopharma's principal executive offices are located at 901 Gateway Boulevard, South San Francisco, CA 94080.
What is the Commission File Number for Theravance Biopharma?
The Commission File Number for Theravance Biopharma is 001-36033.
What is the Standard Industrial Classification (SIC) code for Theravance Biopharma?
The Standard Industrial Classification (SIC) code for Theravance Biopharma is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Theravance Biopharma, Inc. (TBPH).